Beyond Meat Inc (BYND) Stock Price Today
Aura AI Summary
Key Stats
- $314.36MMarket Cap
- -Volume
- Consumer StaplesSector
- $4.2852W High
- $0.5252W Low
- -Typical Hold Time
- $624.35MEnterprise Value
- -Div Yield
- -Trading Activity
Track Beyond Meat Inc (BYND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Beyond Meat Inc has traded between a low of $0.52 and a high of $4.28, highlighting its annual price range. Buy and sell Beyond Meat Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Beyond Meat Inc
Beyond Meat is a provider of plant-based meats, such as burgers, sausage, ground beef, and chicken. Unlike other vegetarian products, Beyond Meat seeks to replicate the look, cook, and taste of meat, is targeted to omnivores and vegetarians alike, and is sold in the meat case. The products are widely available across the U.S. and Canada and in 83 additional countries as well. International revenue represented 31% of 2021 sales. The firm's products are available in retail stores and the food-service channel. In 2019, before the pandemic struck, sales were evenly split between these two channels, although mix stood at 70% retail/30% food service in 2021. We think the recovery from the crisis and new deals with McDonald's and Yum Brands will return food-service sales to nearly 50% in time.
Most Recent News
Grindr stock shows 23.37% growth potential after recent mixed market moves.
Grindr Inc's stock rose 11.04% over the past month but declined 8.81% in the last 10 days, reaching a local low. Despite this recent drop, the stock has a strong growth potential of 23.37%, supported by a robust Piotroski Score of 8, indicating solid...

Global Botulinum Toxin in Urology Market to reach $1.98B by 2035 with 6.08% CAGR, driven by aging population and advanced treatments
The global Botulinum Toxin in Urology Market is projected to grow from approximately USD 1.16 billion in 2026 to USD 1.98 billion by 2035, at a CAGR of 6.08%. Growth is fueled by increasing prevalence of urological disorders like overactive bladder, ...

BioLife Solutions downgraded to Hold amid $1.5B Repligen acquisition and shareholder fairness probe
BioLife Solutions stock was downgraded to a 'Hold' rating with a $31 price target by Lake Street amid its proposed $1.5 billion acquisition by Repligen Corporation. The deal, a cash-and-stock offer, is under legal scrutiny by Halper Sadeh LLC, which ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.